Experiment 534267
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV INFUSION |
| Organism | Empty organism |
| Citation | JAYSON,GC: CROWTHER,D: PRENDIVILLE,J: MC GOWN,AT: SCHEID,C: STERN,P: YOUNG,R: BRENCHLEY,P: CHANG,J: OWENS,S: PETTIT,GR:. (1995). A PHASE I TRIAL OF BRYOSTATIN 1 IN PATIENTS WITH ADVANCED MALIGNANCY USING A 24 HOUR INTRAVENOUS INFUSION.. 72(2) |
| Amount utilized | |
| Compound isolated | |
| Disease | PHASE I TRIAL IN 19 PATIENTS WITH ADVANCED MALIGNANCY, MEDIAN AGE OF 58 YEARS, MEDIAN KARNOFSKY PERFORMANCE STATUS OF 80 AND MEDIAN NUMBER OF PRIOR TREATMENT REGIMENS OF 2. PARTIAL AND MINOR RESPONSES WERE SEEN IN 4 PATIENTS. (WITH OVARIAN AND NON-HODGKIN'S LYMPHOMA). |
| Dose amount | 25.0 MCG |
| Number | 1 |
| Qualitative result | WEAK ACTIVITY |
| Animal | HUMAN ADULT |
| Per unit | SQ M |
| Dose expression | MAXIMUM TOLERATED DOSE |
| Gender | GIVEN TO BOTH SEXES |